ES2148347T3 - Antagonistas del receptor de la bradiquinina pseudo y no peptidica. - Google Patents

Antagonistas del receptor de la bradiquinina pseudo y no peptidica.

Info

Publication number
ES2148347T3
ES2148347T3 ES94929158T ES94929158T ES2148347T3 ES 2148347 T3 ES2148347 T3 ES 2148347T3 ES 94929158 T ES94929158 T ES 94929158T ES 94929158 T ES94929158 T ES 94929158T ES 2148347 T3 ES2148347 T3 ES 2148347T3
Authority
ES
Spain
Prior art keywords
bradykinin
bradiquinine
peptidic
pseudo
receptor antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94929158T
Other languages
English (en)
Inventor
Donald James Kyle
Babu Joseph Mavunkel
Zhijian Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
Scios LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/118,981 external-priority patent/US5444048A/en
Priority claimed from US08/281,907 external-priority patent/US5541286A/en
Priority claimed from US08/281,904 external-priority patent/US5686565A/en
Application filed by Scios LLC filed Critical Scios LLC
Application granted granted Critical
Publication of ES2148347T3 publication Critical patent/ES2148347T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

EN LA INVENCION SE PRESENTAN COMPUESTOS ANTAGONISTAS DE LA BRADIQUININA EN DONDE MUCHOS (O TODOS) LOS ENLACES PEPTIDICOS DE BRADIQUININA SE ELIMINAN PARA OBTENER COMPUESTOS QUE COMPITAN ESPECIFICAMENTE CON LA BRADIQUININA PARA ENLAZARSE AL RECEPTOR DE BRADIQUININA. DE MANERA MAS PARTICULAR, LA INVENCION SE REFIERE A COMPUESTOS QUE TIENEN, SEGUN UNA DISPOSICION ESPACIAL APROPIADA, DOS UNIDADES CARGADAS POSITIVAMENTE QUE LINDAN CON UNA UNIDAD ORGANICA HIDROFOBA Y UNA UNIDAD QUE IMITA LA CONFORMACION DE ESPIRAS BETA.
ES94929158T 1993-09-09 1994-09-09 Antagonistas del receptor de la bradiquinina pseudo y no peptidica. Expired - Lifetime ES2148347T3 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11934193A 1993-09-09 1993-09-09
US11855893A 1993-09-09 1993-09-09
US08/118,981 US5444048A (en) 1992-10-08 1993-09-09 Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US08/118,550 US5552383A (en) 1992-10-08 1993-09-09 Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US28190694A 1994-07-28 1994-07-28
US28190894A 1994-07-28 1994-07-28
US08/281,907 US5541286A (en) 1992-10-08 1994-07-28 Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US08/281,904 US5686565A (en) 1992-10-08 1994-07-28 Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins

Publications (1)

Publication Number Publication Date
ES2148347T3 true ES2148347T3 (es) 2000-10-16

Family

ID=27574846

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94929158T Expired - Lifetime ES2148347T3 (es) 1993-09-09 1994-09-09 Antagonistas del receptor de la bradiquinina pseudo y no peptidica.

Country Status (7)

Country Link
EP (1) EP0716661B1 (es)
JP (1) JPH11500100A (es)
AT (1) ATE191486T1 (es)
CA (1) CA2171446C (es)
DE (1) DE69423899T2 (es)
ES (1) ES2148347T3 (es)
WO (1) WO1995007294A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100360639B1 (ko) * 1994-03-09 2003-01-30 코르텍, 인크. N-치환글리신함유브라디키닌길항제펩티드
DE69601765T2 (de) * 1995-09-07 1999-07-08 Oreal Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
FR2746647B1 (fr) * 1996-03-27 1998-05-15 Oreal Composition apaisante comprenant un extrait d'iridacee
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) * 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
FR2756566B1 (fr) 1996-12-04 1999-01-08 Fournier Ind & Sante Peptides agonistes du recepteur b2 de la bradykinine, procede de preparation et utilisation en therapeutique
WO2002024697A1 (en) * 2000-09-25 2002-03-28 Toray Industries, Inc. Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
JP4712384B2 (ja) 2002-09-09 2011-06-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｏｒｌ−１受容体介在障害の治療に有用なヒドロキシアルキル置換１，３，８−トリアザスピロ［４．５］デカン−４−オン誘導体
JP4861976B2 (ja) 2004-03-11 2012-01-25 アクテリオン ファーマシューティカルズ リミテッド インドール−１−イル酢酸誘導体
US7714132B2 (en) 2004-03-11 2010-05-11 Actelion Pharmaceuticals, Ltd. Tetrahydropyridoindole derivatives
KR101213912B1 (ko) 2004-08-26 2012-12-18 액테리온 파마슈티칼 리미티드 Ｃｒｔｈ2 길항제로서의2-설파닐-벤조이미다졸-1-일-아세틱 애시드 유도체
BRPI0719123A2 (pt) * 2006-09-01 2013-12-17 Cylene Pharmaceuticals Inc Moduladores de serina-treonina proteína cinase e parp
US8703948B2 (en) 2006-11-28 2014-04-22 Janssen Pharmaceutica Nv Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
RU2338745C1 (ru) * 2007-03-21 2008-11-20 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
CA2683598C (en) 2007-04-09 2015-11-17 Janssen Pharmaceutica Nv 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
WO2009120717A2 (en) 2008-03-24 2009-10-01 Medivation Technologies, Inc. Pyrido [3, 4-b] indoles and methods of use
CN102711467A (zh) * 2009-09-23 2012-10-03 梅迪维新技术公司 吡啶并[3,4-b]吲哚类及使用方法
PH12022553378A1 (en) 2020-06-10 2024-03-25 Univ Leuven Kath Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
AU2022306289A1 (en) 2021-07-09 2024-01-18 Aligos Therapeutics, Inc. Anti-viral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009230A1 (en) * 1988-03-25 1989-10-05 Administrators Of The Tulane Educational Fund Therapeutic peptides
CA2106762C (en) * 1991-04-19 2000-10-10 Donald J. Kyle Bradykinin antagonist peptides
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists

Also Published As

Publication number Publication date
CA2171446C (en) 2004-11-23
WO1995007294A1 (en) 1995-03-16
EP0716661A1 (en) 1996-06-19
JPH11500100A (ja) 1999-01-06
DE69423899D1 (de) 2000-05-11
CA2171446A1 (en) 1995-03-16
DE69423899T2 (de) 2000-11-09
ATE191486T1 (de) 2000-04-15
EP0716661B1 (en) 2000-04-05

Similar Documents

Publication Publication Date Title
ES2148347T3 (es) Antagonistas del receptor de la bradiquinina pseudo y no peptidica.
TR199701526T1 (xx) Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
MX9703186A (es) Antagonistas del receptor del neuropeptido y de indolilo.
DK0610743T3 (da) Immunsuppressive aminoethylen-peptider
GR3026740T3 (en) Alkylsiloxanes as adjuvants for agriculture.
WO2001016114A3 (en) Heterocyclic compounds and methods for modulating cxcr3 function
BR9408063A (pt) Antagonistas de receptores de taquicinina que nÆo sÆo pept¡deos
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
HU9603312D0 (en) Novel elastase inhibitors
AU634280B2 (en) Anticoagulant peptides
CA2286296A1 (en) Inhibitors for urokinase receptor
FI943808L (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
CA2004885A1 (en) Anticoagulant peptides
FI922720A0 (fi) Farmakologiskt aktiva amidkarboxylatderivat.
GR3021660T3 (en) Anticoagulant peptides
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
AU2280895A (en) Synthesis n-protected amino acids, especially n-boc-l-propargylglycine by zinc-mediated addition or organic halides to glycine cation equivalent
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
GB9911334D0 (en) Genetic test for equine severe combined immunodeficiency disease
FI941118A7 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
IL86722A (en) Guanidine-related compounds comprising a tetraphenylborate ion and their preparation
TW282449B (es)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 716661

Country of ref document: ES